Page 1 of Clinical Trials for "Exemestane", 119 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane
Last Updated: March 27, 2012
Condition(s): Breast Neoplasms
2
Completed
Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
Last Updated: February 11, 2010
Condition(s): Breast Neoplasms
3
Terminated
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
Last Updated: September 29, 2011
Condition(s): Early Breast Cancer
4
Active, not recruiting
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Last Updated: May 4, 2012
Condition(s): Breast Cancer
5
Terminated
Adjuvant Post-Tamoxifen Exemestane Trial
Last Updated: December 16, 2008
Condition(s): Breast Cancer
6
Recruiting
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Last Updated: May 14, 2012
Condition(s): Her2 Negative Breast Cancer Patients
7
Recruiting
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
Last Updated: May 17, 2012
Condition(s): Lung Cancer; Non Small Cell Lung Cancer (NSCLC); Breast Cancer; ER+ Breast Cancer
8
Completed
Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding
Last Updated: December 22, 2011
Condition(s): Breast Cancer
9
Completed
Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
Last Updated: May 3, 2011
Condition(s): Metastatic Breast Cancer
10
Terminated
Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
Last Updated: January 24, 2012
Condition(s): Metastatic Breast Cancer
11
Recruiting
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
Last Updated: May 18, 2012
Condition(s): Metastatic ER+ Her2- Breast Cancer; Postmenopausal
12
Terminated
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Last Updated: May 9, 2012
Condition(s): Breast Neoplasms
13
Completed
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
Last Updated: June 29, 2011
Condition(s): Metastatic Breast Cancer
14
Completed
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
Last Updated: May 14, 2012
Condition(s): Prostate Cancer
15
Not yet recruiting
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Last Updated: May 22, 2012
Condition(s): Breast Neoplasms
16
Recruiting
Aromasin® Non-Interventional Study Of Early Invasive Breast Cancer Patients In China
Last Updated: May 3, 2012
Condition(s): Breast Neoplasms
17
Recruiting
Study of Aspirin in the Exemestane to Adjuvant Treatment of Breast Cancer
Last Updated: September 8, 2011
Condition(s): Breast Neoplasms
18
Completed
A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Last Updated: January 10, 2012
Condition(s): Breast Cancer; Breast Tumors; Metastatic Cancer
19
Completed
Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant
Last Updated: June 11, 2009
Condition(s): Breast Neoplasms
20
Completed
Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin
Last Updated: July 13, 2010
Condition(s): Breast Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Exemestane%22

Page 1 of Clinical Trials for "Exemestane", 119 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About